Clinical trial
Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland…
NCT00168181 · Alberta Health services, Other · Completed
Key facts
| NCT number | NCT00168181 |
|---|---|
| Title | Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients |
| Official title | A Phase III Randomized Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients |
| Lead sponsor | Alberta Health services, Other |
| Collaborators | CancerCare Manitoba Jewish General Hospital Newfoundland Cancer Treatment & Research Foundation Notre-dame Hospital Ottawa Hospital Research Institute |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer, Head and Neck Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Submandibular gland Transfer, Salagen |
| Enrollment | 220 |
| Start date | Apr 1, 2002 |
| Completion | Apr 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 18, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: